Fang Yang

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study

Shukui Qin, Stephen L. Chan, Shanzhi Gu et al. · The Lancet · 2023 · 590 citations

First-line Therapy, Hepatology, International Phase 3 +8

PDGF Promotes the Warburg Effect in Pulmonary Arterial Smooth Muscle Cells via Activation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway

Yunbin Xiao, Hongyan Peng, Chenliang Hong et al. · Cellular Physiology and Biochemistry · 2017 · 170 citations · Full text

An androgen receptor negatively induced long non-coding RNA ARNILA binding to miR-204 promotes the invasion and metastasis of triple-negative breast cancer

Fang Yang, Yan Shen, Wenwen Zhang et al. · Cell Death and Differentiation · 2018 · 123 citations · Full text

Androgen Receptor, Systems Biology, Breast Oncology +12

<i>ALDH2</i> is associated to alcohol dependence and is the major genetic determinant of “daily maximum drinks” in a GWAS study of an isolated rural chinese sample

Ellen E. Quillen, Xiang‐Ding Chen, Laura Almasy et al. · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · 2013 · 115 citations · Full text

Substance Use, Genetics, Risk Genes +20

Small nucleolar RNA 113–1 suppresses tumorigenesis in hepatocellular carcinoma

Gang Xu, Fang Yang, Cui‐Ling Ding et al. · Molecular Cancer · 2014 · 113 citations · Full text